Peripheral T-cell lymphoma

Common Name(s)

Peripheral T-cell lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Peripheral T-cell lymphoma" returned 183 free, full-text research articles on human participants. First 3 results:

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses.
 

Author(s): Bertrand Coiffier, Barbara Pro, H Miles Prince, Francine Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Franck Morschhauser, Martin Wilhelm, Lauren Pinter-Brown, Swaminathan Padmanabhan Iyer, Andrei Shustov, Tina Nielsen, Jean Nichols, Julie Wolfson, Barbara Balser, Steven Horwitz

Journal:

 

Romidepsin is a structurally unique, potent, bicyclic class 1 selective histone deacetylase inhibitor approved by the US Food and Drug Administration for the treatment of patients with cutaneous T-cell lymphoma who have received ≥ 1 prior systemic therapy and patients with peripheral ...

Last Updated: 10 Feb 2014

Go To URL
Peripheral T-cell lymphoma: what's the role for transplant?
 

Author(s): Jonathon B Cohen, Christopher R Flowers

Journal: Oncology (Williston Park, N.Y.). 2013 Sep;27(9):891-2.

 

Last Updated: 28 Nov 2013

Go To URL
Peripheral T-cell lymphoma: time for a T-cell-centric standard of care.
 

Author(s): Shella Saint Fleur-Lominy, Catherine S Diefenbach

Journal: Oncology (Williston Park, N.Y.). 2013 Sep;27(9):885-6.

 

Last Updated: 28 Nov 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Peripheral T-cell lymphoma" returned 13 free, full-text review articles on human participants. First 3 results:

Peripheral T-cell lymphoma: new therapeutic strategies.
 

Author(s): Adam M Petrich, Steven T Rosen

Journal: Oncology (Williston Park, N.Y.). 2013 Sep;27(9):878-84.

 

Between 2006 and 2011, four new agents gained regulatory approval for the treatment of relapsed/refractory cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). These new approvals, together with recent advances in both combination chemotherapy and transplant strategies, ...

Last Updated: 28 Nov 2013

Go To URL
Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.
 

Author(s): J Yin, J Wei, J H Xu, Y Xiao, Y C Zhang

Journal: Acta Haematol.. 2014 ;131(2):114-25.

 

In view of the poor prognosis of most peripheral T cell lymphoma (PTCL) subtypes treated with conventional chemotherapy such as CHOP/CHOP-like regimens, high-dose chemotherapy followed by autologous stem cell transplantation (HDT/ASCT) seems a reasonable option in eligible patients. ...

Last Updated: 21 Feb 2014

Go To URL
Novel targeted therapies in peripheral T cell lymphoma.
 

Author(s): Deepa Jagadeesh, Mitchell R Smith

Journal: Discov Med. 2013 Jun;15(85):367-78.

 

Peripheral T cell lymphomas (PTCL), non-Hodgkin lymphomas characterized by having features of T cells that have matured in the thymus, are a heterogeneous group of clinical entities. Compared with B cell lymphomas, they are less common, more difficult to diagnose and classify, more ...

Last Updated: 3 Jul 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
 

Status: Recruiting

Condition Summary: Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma

 

Last Updated: 23 Jul 2013

Go to URL
Treatment of Peripheral T-cell Lymphoma
 

Status: Recruiting

Condition Summary: Peripheral T-cell Lymphoma

 

Last Updated: 19 Sep 2013

Go to URL
Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30
 

Status: Recruiting

Condition Summary: Peripheral T-Cell Lymphoma

 

Last Updated: 11 Sep 2014

Go to URL